scispace - formally typeset
R

Robert S. Rosenson

Researcher at Icahn School of Medicine at Mount Sinai

Publications -  455
Citations -  26146

Robert S. Rosenson is an academic researcher from Icahn School of Medicine at Mount Sinai. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 70, co-authored 404 publications receiving 22951 citations. Previous affiliations of Robert S. Rosenson include Cardiovascular Institute of the South & Mount Sinai Hospital.

Papers
More filters
Journal ArticleDOI

Antiatherothrombotic Properties of Statins Implications for Cardiovascular Event Reduction

TL;DR: Experimental animal models suggest that statins may foster stability through a reduction in macrophages and cholesterol ester content and an increase in volume of collagen and smooth muscle cells, which help to explain the early and significant cardiovascular event reduction reported in several clinical trials of statin therapy.
Journal ArticleDOI

ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension

TL;DR: The Expert Consensus Document (ECD) as mentioned in this paper was developed by the American College of Cardiology Foundation (ACCF) Task Task Task Force on Consensus Documents (ECDs) and was cosponsored by AHA.
Journal ArticleDOI

ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use: A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents

TL;DR: The American College of Cardiology Foundation (ACCF) Task Force on Clinical Expert Consensus Documents (ECDs) as mentioned in this paper developed by the ACCF and other cosponsors are intended to inform practitioners, payers, and other interested parties of the opinion of the ACC and document cosponsors concerning evolving areas of clinical practice and/or technologies that are widely available or new to the practice community.
Journal ArticleDOI

Cholesterol Efflux and Atheroprotection Advancing the Concept of Reverse Cholesterol Transport

TL;DR: High-density lipoprotein has been proposed to have several antiatherosclerotic properties, including the ability to mediate macrophage cholesterol efflux, antioxidant capacity, antiinflammatory properties, nitric oxide–promoting activity, and ability to transport proteins with their own intrinsic biological activities.